A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe Biden on lowering prescription drug costs in posts online that suggest President Donald Trump has canceled the $35 insulin co-pay cap for certain Medicare programs.

Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose levels in real-time in non-diabetics.

has announced that the US Food and Drug Administration (FDA) has cleared Tidepool Loop, an automated insulin dosing app intended for the management of type 1 diabetes (T1D) in those six years old ...

This article highlights recent developments in healthcare, including the U.S. FDA's approval of Alzheimer's and diabetes drugs, challenges facing the World Health Organization after funding cuts, lawsuits regarding insulin prices,

It also caps insulin ... could impact drug prices by curbing research into cost-reduction models and suggests that reducing drug prices is not a priority for the Trump administration.

The final proposed model would have had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug Administration (FDA ... such as the $35 per month cap on insulin costs, were not affected by Trump’s executive order.

Newsom’s insulin fail. A drive by California Gov. Gavin Newsom to make low-cost insulin by spending $100 million in state funds has stalled, dashing the hopes of the well-heeled

“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, seriously poorer,” Steven Bechloss—author of the Substack, America, America — posted to the Bluesky social media platform.

While some studies suggest probiotics may help you lose weight and belly fat, more research is needed on their effectiveness. Here are the strains to try.

During his first term, Trump did establish a voluntary, time-limited model capping insulin costs at $35 per month for people on participating Medicare Part D prescription drug plans. KFF ...

Although Mounjaro and insulin have different effects on ... This is the most serious warning from the Food and Drug Administration (FDA). It alerts doctors and patients about drug effects that ...

Beta Bionics hit net sales of $44.7m in the first nine months of 2024, marking an increase from $3.6m in 2023. Beta Bionics’ revenue jump was largely due to the US Food and Drug Administration (FDA) approval of its iLet insulin delivery system for type 1 diabetes in mid-2023.